Journey Medical Corp

Name: Journey Medical Corp standardized financial statements, quarterly
Creator: Listed

DERMNasdaqCIK 1867066HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$17.8m, Q2 FY2026

Operating income$456.0k, Q2 FY2026

Net income−$312.0k, Q2 FY2026

Journey Medical Corp, income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	15.3	15.3	13.0	14.9	14.6	12.6	13.1	15.0	17.0	16.1	15.9	17.8
Cost of revenue	$m	6.4	2.2	6.8	6.5	5.3	2.2	4.8	4.9	not reported	not reported	6.2	6.1
Research and development	$m	2.2	1.5	7.9	0.9	0.8	0.2	0.0	0.0	0.3	0.2	not reported	0.1
Selling, general and administrative	$m	8.6	9.8	8.4	10.3	11.4	10.1	10.6	11.9	12.1	9.9	10.1	10.9
Operating income	$m	17.2	(2.1)	(10.1)	(2.9)	(2.9)	2.2	(3.3)	(2.9)	(1.5)	(0.4)	(1.5)	0.5
Interest expense	$m	0.3	0.0	0.5	0.6	0.8	0.8	0.9	0.9	0.9	0.9	0.9	0.9
Income tax	$m	0.1	0.1	not reported	not reported	not reported	not reported	not reported	0.1	0.0	0.0	not reported	0.0
Net income	$m	16.8	(2.1)	(10.4)	(3.4)	(2.4)	1.5	(4.1)	(3.8)	(2.3)	(1.2)	(2.2)	(0.3)
Diluted EPS	$ per share	0.80	not reported	(0.53)	(0.17)	(0.12)	not reported	(0.18)	(0.16)	(0.09)	not reported	(0.08)	(0.01)
Basic EPS	$ per share	0.91	not reported	(0.53)	(0.17)	(0.12)	not reported	(0.18)	(0.16)	(0.09)	not reported	(0.08)	(0.01)

Balance sheet

Cash and equivalents$25.6m, Q2 FY2026

Long-term debt$20.5m, Q2 FY2026

Shareholders' equity$32.1m, Q2 FY2026

Journey Medical Corp, balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	24.7	27.4	24.1	23.9	22.5	20.3	21.1	20.3	24.9	24.1	27.2	25.6
Current assets	$m	44.7	56.5	47.0	46.5	46.2	48.2	54.0	51.3	56.4	66.9	65.0	72.8
Total assets	$m	65.9	76.8	66.6	65.2	64.0	80.2	85.0	81.2	85.2	94.6	91.5	98.4
Current liabilities	$m	48.5	41.9	38.9	34.1	33.3	35.2	40.2	40.5	39.7	37.4	37.8	45.8
Total liabilities	$m	48.5	56.5	53.6	53.9	53.1	60.2	63.4	61.9	59.3	62.7	60.7	66.2
Long-term debt	$m	0.0	14.6	14.7	19.7	19.8	24.9	23.1	21.4	19.5	25.3	22.9	20.5
Current portion of debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	1.9	3.8	5.6	not reported	2.5	5.0
Short-term borrowings	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	17.4	20.4	13.0	11.3	10.9	20.1	21.5	19.2	25.9	31.9	30.8	32.1

Cash flow

Operating cash flow−$1.7m, Q2 FY2026

Capital expenditure$0, Q4 FY2023

Journey Medical Corp, cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$m	18.7	(16.5)	(5.0)	(5.2)	(1.2)	2.2	(2.8)	(0.9)	(2.4)	(6.3)	2.9	(1.7)
Capital expenditure	$m	0.0	0.0	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)27.49m, Q2 FY2026

Journey Medical Corp, shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	17.6	17.8	18.0	21.0	19.8	20.0	20.5	22.6	23.3	25.0	27.3	27.5

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.

Journey Medical Corp

Income statement

Balance sheet

Cash flow

Shares